Panel Discussion: Where do we See the Dermatology Drug Development Landscape in the Next 5 Years?

Time: 9:00 am
day: Day One


  • Reviewing which inflammatory skin disease holds the most promise for future development
  • Considering whether hidradenitis suppurativa is the next atopic dermatitis
  • Postulating how rare dermatological disease drug development will take shape in the future – how can we prepare for low patient availability and safeguarding against regulatory change